In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Capitol Capsule: White House Medicare Rx horse trading pays off

This article was originally published in Scrip

Executive Summary

Last summer, the White House was highly criticized for the behind-the-scenes wheeling and dealing it conducted in 2009 with the biopharmaceutical industry and other health care sectors over what eventually became the Affordable Care Act (ACA). But those negotiations four years ago resulted in a deal that has paid off in a big way – with Medicare beneficiaries enrolled in the Part D prescription drug program saving a total of $2.5 billion last year on branded medicines, with another 2.8 million seniors and disabled Americans garnering $105 million in discounts for generics.



Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts